Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II

Abstract

22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, ¹⁹⁹Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.

Original language	English
Pages (from-to)	50-53
Number of pages	4
Journal	Terapevticheskii Arkhiv
Volume	67
Issue number	9
Publication status	Published - 1995
Externally published	Yes

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II'. Together they form a unique fingerprint.

Cite this

@article{421db911b4cb4bbaa2b97b4bef50d761,

title = "Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II",

abstract = "22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, 199Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.",

author = "Karpov, {R. S.} and Pavlyukova, {E. N.} and Kapishchenko, {T. D.} and Chernov, {V. I.}",

year = "1995",

language = "English",

volume = "67",

pages = "50--53",

journal = "Terapevticheskii Arkhiv",

issn = "0040-3660",

publisher = "Izdatel'stvo Meditsina",

number = "9",

}

TY - JOUR

T1 - Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II

AU - Karpov, R. S.

AU - Pavlyukova, E. N.

AU - Kapishchenko, T. D.

AU - Chernov, V. I.

PY - 1995

Y1 - 1995

N2 - 22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, 199Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.

AB - 22 patients (mean age 45.08 ± 1.38 years) with essential hypertension stage II were entered in a placebo-controlled blind trial of cilazapril, angiotensin-converting enzyme. A complex of clinical-instrumental tests comprised dipidamol test, bicycle ergometry, 199Tl myocardial scintigraphy, echo-CG. A 3-month course of cilazapril reduced myocardial hypoperfusion in 15 patients, improved left ventricular relaxation. Antiischemia effect of the drug was also evident.

UR - http://www.scopus.com/inward/record.url?scp=0029549390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029549390&partnerID=8YFLogxK

M3 - Article

C2 - 7495043

AN - SCOPUS:0029549390

VL - 67

SP - 50

EP - 53

JO - Terapevticheskii Arkhiv

JF - Terapevticheskii Arkhiv

SN - 0040-3660

IS - 9

ER -

Cilazapril effect on left ventricular function and myocardial perfusion in patients with essential hypertension stage II

Abstract

ASJC Scopus subject areas

Other files and links

Cite this